Mason Carrico

Illumina, Inc. (NASDAQ: ILMN) has come to loggerheads with EU antitrust regulators related to their investigation into the $7.1 billion acquisition of Grail. Although the company faces near-term headwinds, its strong positioning in the large Next Generation Sequencing (NGS) market could propel...